Inflammatory Bowel Disease

Entyvio therapy may improve disease course of immune-mediated diarrhea colitis and decrease steroid exposure, according to a presentation at the American College of Gastroenterology virtual annual meeting.”

Patients with Crohn’s disease in their second year of treatment with Rinvoq showed sustained improvements in disease control, deep remission and quality of life, according to research presented at the American College of Gastroenterology Annual Scientific Meeting.

“I'm doing fine.” “I'm managing.” “I'm doing okay.”

During this year’s ACG 2020 Virtual meeting, Healio will host its annual Disruptive Innovators Award ceremony at 7:30 P.M. on Monday, October 26.

During this year’s ACG 2020 Virtual meeting, Healio will host its annual Disruptive Innovators Award ceremony on Monday, October 26.

In this exclusive video, William Sandborn, MD, from the University of California, San Diego, discusses research presented at UEG Week Virtual that explored the safety and efficacy of Zeposia in ulcerative colitis.

Humira was efficacious and safe for treating children with moderate to severe ulcerative colitis, according to a presentation at UEG Week.

Phase 2 data support the safety and efficacy of mirikizumab in patients with Crohn’s disease, according to results presented at UEG Week.

In this exclusive video, William J. Sandborn, MD, discusses interim results from the phase 2 GALAXI 1 study of Tremfya in patients with Crohn’s disease.

In this exclusive video from UEG Week Virtual, William J. Sandborn, MD, from the University of California, San Diego, discusses the final results from the IM-UNITI long-term extension trial of Stelara in patients with Crohn’s disease.